NASDAQ: HBIOHarvard Bioscience Inc Stock Ownership - Who owns Harvard Bioscience?
Insider buying vs selling
Have Harvard Bioscience Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jennifer Cote | Chief Financial Officer | 2025-03-19 | 5,687 | $0.69 | $3.92kSell |
| James W. Green | Chief Executive Officer | 2025-03-19 | 38,413 | $0.69 | $26.47kSell |
| Jennifer Cote | Chief Financial Officer | 2024-12-29 | 4,731 | $1.98 | $9.37kSell |
| Jennifer Cote | Chief Financial Officer | 2024-12-29 | 3,797 | $1.98 | $7.52kSell |
| James W. Green | Chief Executive Officer | 2024-12-29 | 56,915 | $1.98 | $112.69kSell |
| James W. Green | Chief Executive Officer | 2024-12-29 | 25,310 | $1.98 | $50.11kSell |
HBIO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when HBIO insiders and whales buy or sell their stock.
HBIO Shareholders
What type of owners hold Harvard Bioscience Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Skystone Advisors LLC | 32.69% | 14,452,038 | $7.36M | Insider |
| James W. Green | 9.68% | 4,277,902 | $2.18M | Insider |
| Amh Equity Ltd | 7.66% | 3,387,355 | $1.72M | Institution |
| Chane Graziano | 6.80% | 3,005,150 | $1.53M | Insider |
| Blackrock Inc | 6.38% | 2,820,462 | $1.44M | Institution |
| Hso Limited Partnership | 6.24% | 2,757,257 | $1.40M | Insider |
| Harvey Partners LLC | 4.95% | 2,187,500 | $1.11M | Institution |
| Vanguard Group Inc | 4.84% | 2,138,749 | $1.09M | Institution |
| Royce Associates LP | 4.02% | 1,777,894 | $904.95k | Institution |
| Granahan Investment Management LLC | 3.46% | 1,527,894 | $777.70k | Institution |
HBIO vs Medical Stocks
Harvard Bioscience Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.